Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Olaparib
Study Title: A study to measure olaparib levels in the blood of
participants with advanced solid tumors
Thank you!
Thank you for taking part in the clinical study for the study drug olaparib.
AstraZeneca AB sponsored this study and thinks it is important to share the results
of the study with you. An independent non-profit organization called CISCRP
helped prepare this summary of the study results for you. We hope it helps you
understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in May 2018 and ended in March 2019. The sponsor reviewed
the data collected when the study ended and created a report of the results. This is
a summary of that report.
This study included 18 participants in Belgium.
1